Winton Group LTD Aspira Women'S Health Inc. Transaction History

Winton Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$1.63 - $3.43 $33,478 - $70,448	-20,539 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$3.19 - $5.48 $17,624 - $30,277	-5,525 Reduced 21.2%	20,539 $67,000
Q2 2021 Aug 10, 2021	SELL	$4.78 - $6.84 $999 - $1,429	-209 Reduced 0.8%	26,064 $146,000
Q1 2021 Jul 21, 2021	BUY	$5.9 - $9.13 $48,179 - $74,555	8,166 Added 45.1%	26,273 $177,000
Q4 2020 Feb 12, 2021	BUY	$3.0 - $6.71 $54,321 - $121,497	18,107 New	18,107 $121,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.